ELDN logo

Eledon Pharmaceuticals, Inc. Common Stock


ELDN: Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.


Show ELDN Financials

Consumer Interest
SEC Filings

Recent trades of ELDN by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ELDN's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ELDN in WallStreetBets Daily Discussion


Recent insights relating to ELDN

CNBC Recommendations

Recent picks made for ELDN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ELDN

Corporate Flights

Flights by private jets registered to ELDN